ArticleCancers2023

A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma.

Hao-Kang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.